Rimoni Industries
Company page · Chemicals and plastics

Rimoni Industries

TASE : RIMOISIN : IL0010804560Headquarters: Modi'in-Maccabim-Re'utIFRS accounts · in ₪M

Rimoni Industries Ltd., together with its subsidiaries, engages in industrial design, engineering, mold manufacturing, and precise injection molding and assemblies of products and components in Israel and internationally. Based in Modi'in-Maccabim-Re'ut.

Price₪30.87−0.0% · session of 12/11/2026
Market cap₪259Mprice × number of shares
Next resultsno later than 30/11/2026Quarterly report
1-year price−41.1% over the period
Analysis in brief · H1 2026

Rimoni Industries: net income sharply down (−29.6%), sales down (−8.9%), operating income sharply down (−20.4%).

  • Net income sharply down

    Net income: ₪15M, vs. ₪21M a year earlier, i.e. −29.6%.

    H1 2026
  • Sales down

    Revenue: ₪85M, vs. ₪93M a year earlier, i.e. −8.9%.

    H1 2026
  • Operating income sharply down

    Operating income: ₪19M, vs. ₪24M a year earlier, i.e. −20.4%.

    H1 2026
  • Cash flow down

    Operating cash flow: ₪19M, vs. ₪20M a year earlier, i.e. −4.3%.

    H1 2026
Built automatically from the published figures.
Valuation

What the market pays, vs. the sector

P/E9.2price / net income over 12 months
P/B1.6market cap / equity
Dividend yield13.6%dividends over the last 12 months / price
12-month range₪30.87 – ₪52.43monthly closes

This company's valuation multiples history is being built day by day from now on.

P/E calculated on net income (trailing 12 months: last fiscal year + H1 2026 − same period a year earlier). Sector median: companies in the group tracked here. Prices: Yahoo Finance; market cap cross-checked with the Tel Aviv Stock Exchange for Israeli stocks. These ratios describe a price, not a value: none of them says whether the share is expensive or cheap.

Dividends

Dividend per share, over 5 years

₪6.572021₪4.122022₪2.442023₪4.862024₪5.412025₪3.002026 (to date)

Total dividends per share paid each calendar year (5 year(s) out of 5 with a payment). Source: Yahoo Finance. The current year is not complete.

Follow earnings · WhatsApp group TA-125Details ▾
WhatsApp group · TA-125

Every report from a TA-125 company, analyzed the same day: key figures and year-on-year change, analysis in brief, share price reaction. One daily summary during earnings season.

Detailed figures and history
The figures

Financial summary

S1 2026S1 2025FY 2025
Total assets217228212
Current assets9310087
Non-current assets124128125
Equity166182170
of which minority interests000
Current liabilities454036
Non-current liabilities666
Revenue8593182
Gross profit243155
Operating income192440
Pre-tax income172439
Net income152134
Net income (attributable to shareholders)152134
Dividends paid−180−45
Operating cash flow192043

In millions of shekels. The "H1" columns cover the first six months of the year.

Ratios

Calculated from these figures

S1 2026S1 2025FY 2025
Gross margin28.2%33.5%30.0%
Operating margin22.4%25.6%22.2%
Net margin17.4%22.6%18.9%
Current ratio (current assets / current liabilities)2,1 x2,5 x2,4 x
Equity / total assets76.7%79.9%80.1%

The 5-year history, charts and cross-check models are coming for companies listed only in Tel Aviv: each new filing on Maya is kept and enriches the page.

Company overview

Rimoni Industries Ltd., together with its subsidiaries, engages in industrial design, engineering, mold manufacturing, and precise injection molding and assemblies of products and components in Israel and internationally. It operates through Plastic Casting and Patterns segments. The company offers hardened steel molds for high-volume production, including multi-cavity, hot runner, over-molding, and micro-precision applications. It offers precision plastic components through thermoplastic injection molding techniques. It serves medical, automotive, agricultural, high-tech, and consumer industries.

Source: official company profile (Yahoo Finance), summary. Website: www.rimoni-ind.com

Sources
Information, no recommendation. This site presents figures published by companies and calculations based on those figures. It is not investment advice, nor a recommendation to buy or sell, nor a valuation of the companies. Always check the original reports.